Related Experiment Video
Updated: Dec 20, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Significance of STAT3 in Immune Infiltration and Drug Response in Cancer
Wei Chen1, Xiaoshuo Dai1, Yihuan Chen1
1Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan, China.
Abstract:
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor and regulates tumorigenesis. However, the functions of STAT3 in immune and drug response in cancer remain elusive. Hence, we aim to reveal the impact of STAT3 in immune infiltration and drug response comprehensively by bioinformatics analysis. The expression of STAT3 and its relationship with tumor stage were explored by Tumor Immune Estimation Resource (TIMER), Human Protein Altas (HPA), and UALCAN databases. The correlations between STAT3 and immune infiltration, gene markers of immune cells were analyzed by TIMER. Moreover, the association between STAT3 and drug response was evaluated by the Cancer Cell Line Encyclopedia (CCLE) and Cancer Therapeutics Response Portal (CTRP). The results suggested that the mRNA transcriptional level of STAT3 was lower in tumors than normal tissues and mostly unrelated to tumor stage. Besides, the protein expression of STAT3 decreased in colorectal and renal cancer compared with normal tissues. Importantly, STAT3 was correlated with immune infiltration and particularly regulated tumor-associated macrophage (TAM), M2 macrophage, T-helper 1 (Th1), follicular helper T (Treg), and exhausted T-cells. Remarkably, STAT3 was closely correlated with the response to specified inhibitors and natural compounds in cancer. Furthermore, the association between STAT3 and drug response was highly cell line type dependent. Significantly, the study provides thorough insight that STAT3 is associated with immunosuppression, as well as drug response in clinical treatment.
Insights
Signal transducer and activator of transcription 3 (STAT3) influences cancer immunity and drug response. Lower STAT3 levels correlate with immunosuppression and altered immune cell infiltration, impacting treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Signal transducer and activator of transcription 3 (STAT3) is a key transcription factor involved in tumorigenesis.
- The precise roles of STAT3 in cancer immune infiltration and drug response are not fully understood.
Purpose of the Study:
- To comprehensively investigate the impact of STAT3 on immune infiltration and drug response in cancer using bioinformatics analyses.
- To elucidate the relationship between STAT3 expression, immune cell markers, and therapeutic outcomes.
Main Methods:
- Utilized Tumor Immune Estimation Resource (TIMER), Human Protein Atlas (HPA), and UALCAN databases to analyze STAT3 expression and its relation to tumor stage.
- Employed TIMER for correlation analysis between STAT3 and immune infiltration markers.
- Assessed STAT3's association with drug response using the Cancer Cell Line Encyclopedia (CCLE) and Cancer Therapeutics Response Portal (CTRP) databases.
Main Results:
- STAT3 mRNA levels were generally lower in tumors than normal tissues and showed minimal correlation with tumor stage.
- Protein expression of STAT3 was reduced in colorectal and renal cancers.
- STAT3 expression correlated significantly with immune cell infiltration, including tumor-associated macrophages (TAMs), M2 macrophages, T-helper 1 (Th1) cells, regulatory T cells (Tregs), and exhausted T cells.
- STAT3 demonstrated a strong correlation with responses to specific inhibitors and natural compounds, with notable cell line type dependency.
Conclusions:
- STAT3 is implicated in regulating immune suppression within the tumor microenvironment.
- STAT3 status is a significant predictive biomarker for drug response in cancer therapy.
- Findings offer critical insights into STAT3's dual role in immunosuppression and therapeutic sensitivity, relevant for clinical applications.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
The Tumor Microenvironment

